Share on StockTwits

Research Analysts’ ratings reiterations for Friday, June 20th:

AbbVie (NASDAQ:ABBV) had its outperform rating reaffirmed by analysts at Credit Suisse. They currently have a $60.00 price target on the stock, up from their previous price target of $58.00.

Apartment Investment and Management (NYSE:AIV) had its neutral rating reaffirmed by analysts at JPMorgan Chase & Co.. They currently have a $32.00 target price on the stock, up from their previous target price of $31.00.

Aon Plc (NYSE:AON) had its neutral rating reissued by analysts at Zacks. The firm currently has a $95.00 price target on the stock.

Arrow Electronics (NYSE:ARW) had its neutral rating reiterated by analysts at Zacks. Zacks currently has a $64.00 price target on the stock. Zacks’ analyst wrote, “Arrow posted mixed first-quarter results with the bottom line surpassing the Zacks Consensus Estimate but revenues missing the same. Year-over-year comparisons were modestly up and the company had a favorable book-to-bill ratio. Moreover, positive commentary about enhanced productivity, annual cost savings and continued higher contributions from Europe are encouraging. Moreover, incremental sales from strategic acquisitions, such as Computerlinks, are expected to boost Arrow’s top line, going forward. We believe that Arrow’s core strength of providing best-in-class services and easy-to-acquire technologies are expected to bolster its growth in the future. However, uncertain economic conditions and competition from Avnet and Ingram Micro are concerns, going forward. Thus, we reiterate our Neutral recommendation on Arrow.”

AvalonBay Communities (NYSE:AVB) had its overweight rating reaffirmed by analysts at JPMorgan Chase & Co.. JPMorgan Chase & Co. currently has a $158.00 target price on the stock, up from their previous target price of $153.00.

Avnet (NYSE:AVT) had its neutral rating reiterated by analysts at Zacks. Zacks currently has a $46.00 target price on the stock. Zacks’ analyst wrote, “Avnet posted mixed third-quarter results. The fourth-quarter guidance was less-than-encouraging due to seasonality. Moreover, a significant portion of the company’s revenues comes from the sale of semiconductors, which is a cyclical industry characterized by changes in technology and manufacturing capacity and is subject to significant market upturns and downturns. Nonetheless, we remain encouraged by management’s decision to optimize costs and investments to align the business with changing demand. While Avnet’s leading position in electronics distribution and acquisition synergies are encouraging, it faces stiff competition in both domestic and foreign operations, especially from archrival Arrow Electronics. Thus, we reiterate our Neutral recommendation on Avnet.”

AstraZeneca plc (NYSE:AZN) had its neutral rating reissued by analysts at Zacks. The firm currently has a $79.00 price target on the stock. Zacks’ analyst wrote, “AstraZeneca’s first-quarter 2014 core earnings of $1.17 per ADS missed the Zacks Consensus Estimate of $1.20. Earnings were also down 11% (at CER) year over year. AstraZeneca’s quarterly revenues increased 3% (at CER) year over year to $6.4 billion. Revenues were above the Zacks Consensus Estimate of $6.3 billion. AstraZeneca continues to expect 2014 revenues to decline in the low-to-mid single digits and core earnings to decline in the teens. We expect the top and the bottom line to remain under pressure as Nexium went off-patent in May 2014. We are nonetheless pleased with recent approvals (Epanova, Forxiga and Myalept in the U.S. and Xigduo in the EU) at AstraZeneca. We are also positive on AstraZeneca’s efforts to boost its pipeline. We maintain a Neutral recommendation on the stock.”

BlackBerry (NASDAQ:BBRY) had its neutral rating reiterated by analysts at Nomura. They currently have a $10.00 price target on the stock, up from their previous price target of $9.00.

BlackBerry (NASDAQ:BBRY) had its sector underperformer rating reaffirmed by analysts at CIBC. The firm currently has a $6.25 target price on the stock, up from their previous target price of $5.00.

Bristol-Myers Squibb (NYSE:BMY) had its neutral rating reiterated by analysts at Zacks. The firm currently has a $50.00 price target on the stock. Zacks’ analyst wrote, “Bristol-Myers’ first quarter 2014 adjusted earnings of $0.46 per share beat the Zacks Consensus Estimate by $0.02. Adjusted earnings were 12% above the year-ago figure due to lower costs. Net sales (including the diabetes business) however slipped 1% to $3.8 billion. Key oncology drugs performed very well in the quarter. Bristol-Myers has been trying to offset the declining sales of some of its important products by bringing in new products. We are positive on Bristol-Myers’ decision to sell its underperforming diabetes portfolio. We are also impressed by the company’s efforts to develop its pipeline. We believe that the stock is fairly valued at current levels with limited scope for appreciation and hence retain our Neutral recommendation.”

Companhia Brasileira de Distribuicao (NYSE:CBD) had its neutral rating reaffirmed by analysts at Zacks. They currently have a $50.00 target price on the stock. Zacks’ analyst wrote, “Companhia Brasileira de Distribuicao started 2014 on a strong note recording double-digit increase in earnings and sales, despite tough macroeconomic conditions. CBD profits increased 22.9% (in local currency) year over year driven by solid sales growth, improved comps and lower selling, general and administrative expenses. Consolidated gross sales increased 10.8% year over year driven by accelerated organic expansion. Comps growth of 6.3% was driven by growth in all the segments – GPA Food, Viavarejo and Nova Pontocom. Overall, we are encouraged by the company’s efforts to enhance its e-commerce business through new websites and online shopping malls. However, currency translation headwinds and tough economic conditions remain a threat. We expect slow recovery in the macroeconomic conditions in the country and consumer sentiment is likely to recover at a mild pace. We therefore remain Neutral on the stock.”

CBL & Associates Properties (NYSE:CBL) had its overweight rating reissued by analysts at Barclays. The firm currently has a $21.00 target price on the stock, up from their previous target price of $19.00.

Charter Communications (NASDAQ:CHTR) had its neutral rating reaffirmed by analysts at Macquarie. The firm currently has a $155.00 price target on the stock, up from their previous price target of $135.00.

Concur Technologies (NASDAQ:CNQR) had its neutral rating reissued by analysts at Zacks. Zacks currently has a $98.00 target price on the stock. Zacks’ analyst wrote, “Concur is a leading provider of integrated travel and expense management solutions. We are reaffirming our Neutral recommendation on Concur Technologies with a target price of $98. The company’s second quarter witnessed strong new customer growth across the segments, thereby strengthening its travel management business. Further, Concur’s performance in SMB and enterprise business remained strong in the quarter. This apart, the company launched a number of novel apps like ExpenseIt and TripIt among others which are already witnessing momentum. The Concur App Center is also performing well. However, the company’s business is dependent on maintaining strategic relationships with other entities. Further, the increasing expenses are proving to be a drag on company’s financials.”

Coach (NYSE:COH) had its neutral rating reaffirmed by analysts at Citigroup Inc.. They currently have a $36.00 target price on the stock, down from their previous target price of $50.00.

Coach (NYSE:COH) had its equal weight rating reaffirmed by analysts at Barclays. Barclays currently has a $34.00 price target on the stock, down from their previous price target of $45.00.

Coach (NYSE:COH) had its neutral rating reissued by analysts at Sterne Agee. They currently have a $33.00 price target on the stock, down from their previous price target of $41.00.

Coach (NYSE:COH) had its overweight rating reiterated by analysts at JPMorgan Chase & Co.. They currently have a $39.00 price target on the stock, down from their previous price target of $49.00.

Camden Property Trust (NYSE:CPT) had its neutral rating reaffirmed by analysts at JPMorgan Chase & Co.. The firm currently has a $72.00 target price on the stock, down from their previous target price of $73.00.

CenturyLink (NYSE:CTL) had its neutral rating reaffirmed by analysts at Zacks. They currently have a $39.00 price target on the stock.

Cosan Limited (NYSE:CZZ) had its neutral rating reiterated by analysts at Zacks. Zacks currently has a $15.00 price target on the stock. Zacks’ analyst wrote, “Cosan reported net income of R$256 million in first-quarter 2014, up from R$27 million in the year-ago quarter. Earnings came in at US$0.62 per ADR. Revenues grew 8.4% due to higher fuel, ethanol and sugar sales. Energy cogeneration revenues soared 108% while Transportation revenues increased 21%. For 2014, management guided EBITDA in the R$4.15-R$4.65 billion range and capital expenditure to be within R$2.5 R$2.8 billion. In addition to results, long-term growth prospects are bright on the back of Cosan’s strategic acquisitions and growing sugar and ethanol demand. However, rising costs and expenses, adverse impacts of unfavorable weather conditions and higher debt levels might prove to be impediments to growth. Considering these, we maintain a Neutral recommendation on the stock.”

EMC (NYSE:EMC) had its neutral rating reiterated by analysts at Zacks. The firm currently has a $28.00 target price on the stock.

Equity Residential (NYSE:EQR) had its neutral rating reiterated by analysts at JPMorgan Chase & Co.. The firm currently has a $62.00 target price on the stock, up from their previous target price of $61.00.

Essex Property Trust (NYSE:ESS) had its overweight rating reaffirmed by analysts at JPMorgan Chase & Co.. The firm currently has a $189.00 price target on the stock, up from their previous price target of $186.00.

Corning (NYSE:GLW) had its neutral rating reaffirmed by analysts at Zacks. They currently have a $23.00 price target on the stock. Zacks’ analyst wrote, “Corning is primarily a developer of advanced glass substrates for multiple markets. First quarter earnings beat the Zacks Consensus Estimate, although the GG business remained soft, impacted by pricing. Management provided positive guidance, indicating stronger results in the next quarter. The weaker-than-expected demand for touch-screen computing devices impacted revenues, but Corning’s strong position in other markets should not be discounted. Additionally, while Corning’s huge debt balance adds to its risk, net cash remains positive and interest payments small with respect to earnings. Thus, we have Neutral recommendation on Corning shares.”

Hudson City Bancorp (NASDAQ:HCBK) had its neutral rating reaffirmed by analysts at Zacks. The firm currently has a $10.50 price target on the stock. Zacks’ analyst wrote, “Hudson City’s first-quarter 2014 earnings per share outpaced the Zacks Consensus Estimate. Results were aided by increased non-interest income and a fall in expenses along with no provision for loan-losses in the quarter. However, these were partly offset by lower net interest income. A strong capital position and improved credit quality were among other positives. The company announced its agreement with M&T Bank Corp. back in Aug 2012, under which the former will merge into a subsidiary of M&T Bank. Though the deal is a strategic fit for Hudson City, the persistent delay in completion of the deal owing to regulatory issues poses a concern for the company’s future growth prospects. Moreover, a protracted economic recovery and stringent regulations are likely to dampen the company’s financials in the near term.”

IHS (NYSE:IHS) had its overweight rating reissued by analysts at Barclays. They currently have a $150.00 target price on the stock, up from their previous target price of $140.00.

IHS (NYSE:IHS) had its buy rating reiterated by analysts at Deutsche Bank. The firm currently has a $154.00 price target on the stock, up from their previous price target of $140.00.

ITC Holdings Corp. (NYSE:ITC) had its buy rating reissued by analysts at Deutsche Bank. Deutsche Bank currently has a $38.50 target price on the stock, down from their previous target price of $41.00.

Jazz Pharmaceuticals plc – (NASDAQ:JAZZ) had its neutral rating reiterated by analysts at Zacks. Zacks currently has a $157.00 price target on the stock. Zacks’ analyst wrote, “Jazz’s first-quarter earnings of $1.51 per share were above the year-ago earnings of $1.25 per share. Quarterly revenues increased 26% year over year to $246.9 million. We are encouraged by the strong growth exhibited by key products, Xyrem and Erwinaze. Both should continue performing well. We are also positive on Jazz’s efforts to boost sales through label expansion. The Gentium acquisition also looks good. We believe the company will continue to pursue such deals to boost its product portfolio and pipeline. Meanwhile, the Xyrem patent litigation is a matter of concern. We maintain a Neutral recommendation on the stock.”

Kellogg Company (NYSE:K) had its neutral rating reiterated by analysts at Zacks. The firm currently has a $70.00 price target on the stock. Zacks’ analyst wrote, “The first quarter of 2014 was another weak one for Kellogg as U.S. cereal sales remained soft and international results weakened from the last quarter. Though first-quarter adjusted earnings of $1.01 per share beat the Zacks Consensus Estimate, it declined 1% year over year due to weak revenues and profits. Revenues declined 3.1% in the quarter once again due to choppy cereal sales. Despite the near-term weakness, we have faith in Kellogg’s strong fundamentals. We are encouraged by Kellogg’s solid brand positioning, geographic diversity and significant investments in innovation, marketing and supply-chain initiatives. We are also encouraged by the growth potential, diversification and international presence that the Pringles deal provides. Brand building investments and costs saving programs are expected to build as the year unfolds which management believes will benefit organic sales. Still, our expectations for sales acceleration are muted as the cereal category continues to contract.”

KBR (NYSE:KBR) had its outperform rating reissued by analysts at Macquarie. Macquarie currently has a $28.00 target price on the stock, down from their previous target price of $33.00.

Michael Kors Holdings (NASDAQ:KORS) had its overweight rating reaffirmed by analysts at JPMorgan Chase & Co.. The firm currently has a $104.00 target price on the stock, up from their previous target price of $100.00.

The Kroger (NYSE:KR) had its overweight rating reissued by analysts at JPMorgan Chase & Co.. JPMorgan Chase & Co. currently has a $56.00 price target on the stock, up from their previous price target of $53.00.

The Kroger (NYSE:KR) had its buy rating reaffirmed by analysts at Deutsche Bank. They currently have a $55.00 price target on the stock, up from their previous price target of $50.00.

The Kroger (NYSE:KR) had its equal weight rating reiterated by analysts at Barclays. Barclays currently has a $48.00 price target on the stock, up from their previous price target of $40.00.

Liberty Interactive (Interactive group) (NASDAQ:LINTA) had its neutral rating reiterated by analysts at Zacks. Zacks currently has a $31.00 price target on the stock. Zacks’ analyst wrote, “Liberty Interactive reported first-quarter 2014 financial results wherein both its top and bottom line missed the Zacks Consensus Estimate. We believe that the company’s TV home shopping business will continue to flourish. The QVC segment has transformed itself into a powerful global brand, which may boost Liberty Interactive’s revenues in the double-digits. Liberty Interactive’s strategy to offer QVC programs on wireless platforms, such as smartphones and tablets, was an instant hit. On the other hand, persistent global economic headwinds and volatile foreign exchange rates may affect the top line in the near future. Meanwhile, the stock price has soared over 34% in the last year and is currently trading at the high-end of its 52-week price range. We, thus, reiterate our Neutral recommendation on Liberty Interactive.”

Mastercard (NYSE:MA) had its neutral rating reaffirmed by analysts at Zacks. Zacks currently has a $78.00 target price on the stock.

Macerich (NYSE:MAC) had its neutral rating reissued by analysts at Zacks. Zacks currently has a $70.00 price target on the stock.

Merrimack Pharmaceuticals (NASDAQ:MACK) had its overweight rating reissued by analysts at JPMorgan Chase & Co.. The firm currently has a $14.00 target price on the stock, down from their previous target price of $15.00.

Marriott International (NYSE:MAR) had its neutral rating reaffirmed by analysts at Zacks. They currently have a $67.00 target price on the stock. Zacks’ analyst wrote, “Marriott posted solid first quarter 2014 results. Adjusted earnings of $0.55 per share beat the Zacks Consensus Estimate and went up 27.9% year over year driven by an increase in occupancy and room rates in North America. Despite fewer days in the first quarter of 2014 compared to the year-ago period, revenues increased year over year and also beat the Zacks Consensus Estimate driven by top-line increases at all its segments and solid revenue per available room. The company also increased its financial outlook for 2014 driven by its strong development pipeline, which would help it to gain further market share of the hospitality industry. The company is progressing well on the back of a growing North American business, significant international exposure and an aggressive buyback strategy. However, lingering political uncertainty in Latin America and in some parts of Africa and an economic slowdown in China are expected to limit sales growth in international markets. Moreover, an uncertain political situation in Ukraine will have a negative impact on the Eurozone, thereby impacting revenues. “

Petroleo Brasileiro SA (NYSE:PBR) had its neutral rating reissued by analysts at Zacks. The firm currently has a $16.00 price target on the stock. Zacks’ analyst wrote, “We are maintaining our Neutral stance on the Brazilian state-run energy giant Petrobras, reflecting a balanced risk/reward profile. Going forward, the main growth driver will likely be Petrobras’ aim to place itself among the top five oil companies in the world by 2030. We applaud the company’s initiative to cut operating expenses through a cost optimization program. However, we are concerned about Petrobras’ declining production trend. The huge investment requirements and the possibility of heightened state interference add to the negative opinion. Consequently, we expect Petrobras’ growth potential to be restrained. “

Principal Financial Group (NYSE:PFG) had its neutral rating reaffirmed by analysts at Zacks. They currently have a $52.00 price target on the stock. Zacks’ analyst wrote, “Principal Financial’s first-quarter earnings surpassed the Zacks Consensus Estimate as well as year-ago number. Increased focus on fee-based businesses along with improved investment income aided the top-line growth, which more than offset the escalation in expenses, thereby leading to solid results at Principal Financial. The company continues to focus on strategic opportunities to strengthen its asset accumulation and asset management businesses. Increased focus on fee-based revenue sources has been helping the company earn steadily and return capital to its shareholders through share buybacks and dividends. The board approved a 43% hike in dividend and a $200 million share buyback authorization. Moreover, a fee-based business model limits exposure to the interest rate environment. Principal Financial remains focused on a capital deployment target of $500 million to $700 million. However, expenses continue to witness rise. “

Post Properties (NYSE:PPS) had its neutral rating reissued by analysts at JPMorgan Chase & Co.. JPMorgan Chase & Co. currently has a $52.00 target price on the stock, up from their previous target price of $50.00.

Phillips 66 (NYSE:PSX) had its neutral rating reaffirmed by analysts at Zacks. The firm currently has a $90.00 price target on the stock. Zacks’ analyst wrote, “We are initiating coverage on one of the world’s largest independent refiners, Phillips 66 with a Neutral recommendation. Our bullishness stems from the refiner’s diversified presence across the U.S. supported by extensive transportation and logistics assets which provide steady supply of crude from domestic, Canadian and international sources. We believe management’s steady dividend increases, the ongoing share repurchase program and recent acquisition of Beaumont Terminal could further boost shareholder value. However, we find the current valuation fair and adequately reflecting the company’s growth prospects. Moreover, Phillips 66′s capital intensive core business is also faced with a high degree of volatility. This is expected to limit its ability to post positive earnings surprises. As a result, our long-term total return expectation for Phillips 66 remains muted. “

REGAL-BELOIT CORPORATION (NYSE:RBC) had its buy rating reaffirmed by analysts at KeyCorp. The firm currently has a $88.00 target price on the stock, up from their previous target price of $82.00.

Gibraltar Industries (NASDAQ:ROCK) had its outperform rating reissued by analysts at Zacks. The firm currently has a $19.00 price target on the stock. Zacks’ analyst wrote, “Gibraltar Industries reported disappointing results for the first quarter of 2014, with year over year decline in both earnings and revenues. The company reported a loss of $0.05 per share due to negative impacts from harsh weather. However, this factor is considered a positive for the second quarter, as the company is expected to realize benefits from contracts deferred in the first quarter. Gibraltar Industries also foresees a rise in organic revenues in the quarters to come. An increase in the global construction activities is bound to benefit the company. The residential repair and remodeling activities are expected to boost its revenues. The company also plans to go for further inorganic growth. Moreover, Gibraltar Industries boasts a strong cash balance, which will be used for further acquisitions as well as reinvestment in the business for organic growth. Based on the above factors, we maintain our recommendation on the stock at Outperform.”

Sears Holdings Corp. (NASDAQ:SHLD) had its neutral rating reiterated by analysts at Zacks. Zacks currently has a $43.00 target price on the stock. Zacks’ analyst wrote, “We remain cautious about Sears Holdings’ future performance as decline in sales continues to weigh on its bottom-line results. This is evident from first-quarter fiscal 2014 loss of $2.24 per share. The persistent sluggish performance at its Sears Domestic and Kmart stores – owing to Wal-Mart and dollar stores’ aggressive pricing and expansion strategies are drags on the company’s top-line results. However, we commend Sears Holdings’ efforts to improve its financial performance and liquidity position through various strategic measures. Moreover, the company is focused on cost containment, inventory management and merchandise enhancement initiatives to inflate margins. The company’s strategy of capitalizing on opportunities and returning to profitability through its simplified organizational structure and new operating model are also encouraging. Given the above pros and cons we have maintained our long-term Neutral recommendation on the stock.”

Six Flags Entertainment Corp (NYSE:SIX) had its outperform rating reaffirmed by analysts at Credit Suisse. They currently have a $49.00 target price on the stock, up from their previous target price of $47.00.

Symmetry Medical (NYSE:SMA) had its neutral rating reaffirmed by analysts at Zacks. The firm currently has a $9.25 target price on the stock. Zacks’ analyst wrote, “We reaffirm our Neutral recommendation on Symmetry Medical. The company’s 2014-first quarter earnings surged 75% to $0.07 but lagged the Zacks Consensus Estimate by $0.02. However, top line of $101.3 million rose 2.4% and beat the mark. The company’s decision to divest U.K. based Clamonta will benefit in the long-run but negatively affect 2014 earnings and revenues. The new high-margin Surgical business continues to face headwinds, but we believe that long-term prospects of this business are still intact. New products, harmonized sales force and eventual accretion from acquired businesses should also bolster the company’s growth going forward. We set a target of $9.25 on the stock.”

Sanofi SA (NYSE:SNY) had its neutral rating reissued by analysts at Zacks. The firm currently has a $57.00 target price on the stock. Zacks’ analyst wrote, “Sanofi’s first quarter 2014 business earnings of $0.80 per ADS were below the Zacks Consensus Estimate of $0.84. First quarter net sales decreased 2.7% on a reported basis but increased 3.5% at CER. The company expects 2014 business EPS to increase in the range of 4%-7% (CER). We are pleased with Sanofi’s deals with Regeneron, Alnylam and UCB. We expect to see more activity on the deal/acquisition front in 2014. Although Sanofi has some promising pipeline candidates (Toujeo, Cerdelga and alirocumab), we are disappointed with the string of pipeline setbacks at the company in the recent past. We maintain a Neutral recommendation on the stock. “

Tibco Software (NASDAQ:TIBX) had its hold rating reaffirmed by analysts at Deutsche Bank. Deutsche Bank currently has a $19.00 target price on the stock, up from their previous target price of $17.00.

Toll Brothers (NYSE:TOL) had its neutral rating reissued by analysts at Zacks. They currently have a $38.00 price target on the stock. Zacks’ analyst wrote, “Exceeding the Zacks Consensus Estimate 24%, Toll Brothers’ adjusted earnings of $0.31 per share rose significantly from $0.07 in the prior-year quarter on the back of strong revenues and margins. Reported revenues also beat the Zacks Consensus Estimate by 3.1%. Also, revenues grew 67.0% year over year as aggressive pricing made up for flat orders. The company is gaining from its aggressive investment in well-positioned land, strong liquidity position and greater pricing power in the luxury housing market. Moreover, its acquisition of the homebuilding business of Shapell Industries has strengthened its presence in the upscale Californian housing market. However, rising interest rates, rising land, labor and material cost act as headwinds for the company. We therefore have a Neutral recommendation on the stock.”

UDR (NYSE:UDR) had its overweight rating reaffirmed by analysts at JPMorgan Chase & Co.. They currently have a $29.00 price target on the stock, up from their previous price target of $28.00.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.